Healthtech Startups

Guangzhou Yinming Biomedical Technology is a China-based company developing novel drugs in-house, with a pipeline spanning ophthalmic therapies, recombinant protein botulinum toxin, cancer immunotherapy, and pet immunology drugs. Its research is led by a team of scientists and its main candidates have reached the clinical stage.

1 investor

SCHOTT MINIFAB provides contract design, development, and manufacturing services for life science research and diagnostic consumables, including cleaned and coated substrates for in vitro diagnostics and research applications. It specializes in microarray, microfluidic, and injection molding techniques and serves product developers in the diagnostics and life science tools market, with production in the United States, Germany, and Australia.

1 investor

Miniique is a cloud-based electronic medical records system designed for veterinary hospitals that consolidates appointment scheduling, clinical notes, billing, and management operations. The platform serves veterinary clinics of all sizes across Japan with an intuitive interface designed for users with limited IT experience.

1 investor

Minset builds an AI-driven revenue cycle management platform for healthcare providers, aimed at reducing claim denials and getting practices paid faster. It positions itself as an autonomous alternative to manual, staff-heavy billing processes.

1 investor

Miphic provides imaging-based diagnostic screening of mitochondrial function to identify drug efficacy and personalized treatment options for cancer, neurodegenerative disease, diabetes, and aging-related conditions. The platform screens up to 96 conditions simultaneously to support drug discovery, personalized medicine selection, and metabolic research.

1 investor

MiraDx develops genetic biomarker tests, such as PREVIOTOX and PROSTOX Ultra, that help physicians assess cancer patients' risk of treatment-related toxicity and response to therapies like immunotherapy and radiation. The company applies novel biomarkers, including the inherited KRAS-variant, to support more personalized cancer care decisions.

1 investor

Mira Health offers an AI phone concierge that answers patient calls around the clock, identifies the reason for each call, and routes patients to the right provider within a medical practice. It also handles eligibility and cost-of-care checks, refills, messaging, and scheduling for multi-provider clinics.

1 investor

Miramace offers a personal health advocate service, covered by Medicare, that helps individuals set healthcare goals and provides ongoing support via message or call. It serves Medicare-eligible patients seeking guidance in navigating their care.

1 investor

MiraBiologics is a Japanese biopharmaceutical drug discovery company that uses its LassoGraft Technology to graft cyclic peptides onto scaffold proteins for the development of novel biologics. It pursues collaborative R&D partnerships to create innovative biopharmaceuticals.

1 investor

Mirada develops medical imaging software solutions that personalize image-guided cancer treatment to improve patient outcomes. The company combines scientific advancement, technical innovation, and clinical expertise to accelerate cancer care delivery.

1 investor

MFC Co., Ltd. manufactures active pharmaceutical ingredients (APIs) and key starting materials, and conducts R&D and mass production in pharmaceuticals and materials. Using high-purity crystallization technology, it develops and supplies Statin-class APIs such as TBFA and TPPBr, focusing on domestic production of imported pharmaceutical ingredients in South Korea.

1 investor

Mirae is a mobile application that helps people with inflammatory bowel disease understand their condition, track clinical and daily experience data, and prepare for conversations with healthcare providers. The app combines patient-reported symptoms and clinical information to give people with IBD a clearer picture of their disease without replacing clinical judgment.

1 investor

Miraka provides clinician-led cardiac care delivered at home, using continuous real-time monitoring of biometrics such as heart rhythm, blood oxygen, and blood pressure to detect emerging risks and escalate treatment early. It serves cardiac patients between hospital visits, aiming to reduce hospital readmissions, and works via physician referrals at health systems.

1 investor

Miramoon Pharma develops neuroprotective small molecule therapies targeting degenerative disorders including ophthalmology, skeletal and cardiac muscle diseases, and central nervous system conditions. The company was spun out from the University of the Basque Country and Biogipuzkoa Health Research Institute.

1 investor

Miranza operates a network of ophthalmology clinics in Spain specializing in eye care and vision health, offering treatments such as cataract surgery and intraocular lens implants. It serves patients across more than 30 clinics in cities including Barcelona, Madrid, Alicante, Tenerife, and Seville.

1 investor

Miraqules develops biomaterial-based wound healing products for point-of-care medical applications. The company creates affordable, fast-acting solutions including products like StopBleed and InstaBrin, targeting the global healthcare market.

1 investor

Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects. It targets patients and physicians seeking safer alternatives to prescription opioids.

1 investor

Miri offers a subscription-based health program aimed at GLP-1 medication users, helping providers retain customers through ongoing monthly engagement. The product is positioned to improve program retention and generate recurring revenue for the businesses that deploy it.

1 investor

Mirxes develops RNA-based molecular diagnostics for early cancer detection, treatment selection, and multiomics research. Its offerings span cancer screening blood tests, next-generation sequencing panels, and bioinformatics services for clinical and research partners.

1 investor

Mishe operates a direct payor platform that connects employers and members directly with health systems and providers, enabling same-day payments to providers and zero-cost network benefits for members. The platform handles direct contracting, care coordination, and claims processing, including pre-funded treatments with same-day EFT remittance.

1 investor

MISO Chip develops microfluidic systems and diagnostic technologies for oncology, drug development, and precision medicine applications. The company serves biologists, physicians, and clinical researchers seeking to accelerate the translation of biomedical discoveries into patient treatments.

1 investor

A performance lifestyle brand that creates cooling apparel and wearable technologies designed to manage heat and enhance comfort during athletic and everyday activities. Products are engineered with scientific backing and tested by professional athletes.

1 investor

Mission Accomplished is an AI-powered app that helps parents and caregivers break down everyday challenges with their children into small, manageable steps and understand what may be behind a child's behavior. It also connects teachers and clinicians such as SLPs, OTs, and behavioral specialists so everyone supporting a child works from the same information.

1 investor

Mission is a veterinarian-led operator and support network for veterinary hospitals, providing back-office support, resources, and partnership models (including for Founding Lead DVMs) while preserving hospitals' medical autonomy. It serves veterinarians and animal hospitals across the United States.

1 investor